Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial.
Publication
, Journal Article
Bhatt, AS; Vaduganathan, M; Patel, RB; Fonarow, GC; Subacius, HP; Konstam, MA; Zannad, F; Butler, J; Greene, SJ
Published in: Eur J Heart Fail
January 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Eur J Heart Fail
DOI
EISSN
1879-0844
Publication Date
January 2020
Volume
22
Issue
1
Start / End Page
164 / 167
Location
England
Related Subject Headings
- Ventricular Function, Left
- Treatment Outcome
- Tolvaptan
- Stroke Volume
- Patient Discharge
- Middle Aged
- Male
- Humans
- Hospitalization
- Hemodilution
Citation
APA
Chicago
ICMJE
MLA
NLM
Bhatt, A. S., Vaduganathan, M., Patel, R. B., Fonarow, G. C., Subacius, H. P., Konstam, M. A., … Greene, S. J. (2020). Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial. Eur J Heart Fail, 22(1), 164–167. https://doi.org/10.1002/ejhf.1651
Bhatt, Ankeet S., Muthiah Vaduganathan, Ravi B. Patel, Gregg C. Fonarow, Haris P. Subacius, Marvin A. Konstam, Faiez Zannad, Javed Butler, and Stephen J. Greene. “Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial.” Eur J Heart Fail 22, no. 1 (January 2020): 164–67. https://doi.org/10.1002/ejhf.1651.
Bhatt AS, Vaduganathan M, Patel RB, Fonarow GC, Subacius HP, Konstam MA, et al. Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial. Eur J Heart Fail. 2020 Jan;22(1):164–7.
Bhatt, Ankeet S., et al. “Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial.” Eur J Heart Fail, vol. 22, no. 1, Jan. 2020, pp. 164–67. Pubmed, doi:10.1002/ejhf.1651.
Bhatt AS, Vaduganathan M, Patel RB, Fonarow GC, Subacius HP, Konstam MA, Zannad F, Butler J, Greene SJ. Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial. Eur J Heart Fail. 2020 Jan;22(1):164–167.
Published In
Eur J Heart Fail
DOI
EISSN
1879-0844
Publication Date
January 2020
Volume
22
Issue
1
Start / End Page
164 / 167
Location
England
Related Subject Headings
- Ventricular Function, Left
- Treatment Outcome
- Tolvaptan
- Stroke Volume
- Patient Discharge
- Middle Aged
- Male
- Humans
- Hospitalization
- Hemodilution